Multivalent Linkers for Antibody Labeling Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunodetection assays face challenges such as inconsistent labeling, damage to epitope sites, antibody cross-reactions, and the inability to multiplex primary antibodies from the same species due to high koff rates and cross-reactivity of traditional secondary antibodies.
Innovation Solution
The development of artificial multivalent linkers that specifically bind and label primary antibodies with high affinity, utilizing a plurality of peptide binding arms capable of binding to epitopes on a target antigen, and a linker segment covalently linked to these binding arms, thereby reducing cross-linking and enhancing binding specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional secondary antibodies are used for labeling primary antibodies, then labeling can be achieved, but cross-reactions and high koff rates occur leading to signal leaking
Solution Approach 1:
The patent segments the binding function into multiple independent peptide binding arms (typically 2-10 arms) within a single linker molecule. Each arm independently binds to epitopes on the primary antibody, creating a multivalent interaction that increases specificity and reduces cross-reactions compared to traditional single-secondary antibody approaches
Solution Approach 2:
The patent creates composite multivalent linker structures combining multiple peptide binding arms with a central linker segment. These composite structures integrate the functions of multiple antibodies into a single molecule, achieving high specificity through multivalent binding while eliminating the cross-reactivity issues of traditional secondary antibodies
2Reliability
If traditional secondary antibodies are used, then labeling can be performed, but high koff rates cause dissociation and signal leaking
Solution Approach 1:
The patent merges multiple binding arms into a single multivalent linker molecule that binds to multiple epitopes on the primary antibody simultaneously. This multivalent binding creates a stable complex with low koff rates, preventing dissociation and signal leaking that occurs with traditional secondary antibodies
Solution Approach 2:
The patent transitions from monovalent binding (single antibody-antigen interaction) to multivalent binding (multiple interactions simultaneously). This dimensional change in binding valency dramatically increases binding stability and reduces dissociation rates by creating a network of interactions rather than single-point binding
3Adaptability or versatility
If primary antibodies from the same species are multiplexed, then detection capability increases, but cross-reactivity prevents simultaneous use
Solution Approach 1:
The patent segments the binding function into multiple independent peptide binding arms that can be designed to recognize different epitopes. This segmentation allows each arm to be optimized for specific epitope recognition, enabling multiplexing of primary antibodies from the same species by using linkers with arms targeting different epitopes
Solution Approach 2:
The patent creates universal multivalent linker platforms that can be configured with different peptide binding arms to recognize different epitopes. This multi-functionality allows the same linker architecture to support multiplexing of multiple primary antibodies from the same species by simply changing the epitope-specific peptide arms
4Ease of manufacture
If direct labeling of primary antibodies is performed, then assay simplicity increases, but inconsistent labeling and epitope damage occur
Solution Approach 1:
The patent introduces multivalent linkers as intermediary molecules between the primary antibody and the detection system. This intermediary approach eliminates direct chemical labeling of primary antibodies, preventing epitope damage and inconsistent labeling while maintaining assay simplicity through a standardized linker-based detection platform
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multivalent linkers achieve high specificity and low dissociation rates (koff) from the target antigen, allowing for efficient labeling of primary antibodies and enabling multiplexing of antibodies from the same species without signal leaking, thus improving the reliability and efficiency of immunodetection assays.
Implementation Method 1
a multivalent linker that specifically binds a target antigen... each binding arm capable of binding to an epitope in the same target antigen... binds to the antibody with a koff(s−1) rate of less than or equal to 1.0×10−4
Data Source
AI summary
The disclosure relates to the use of multivalent linkers to label targets (e.g., primary antibodies). The disclosure provides methods of labeling antibody with a reporter/dye/enzyme via the multivalent linker. The disclosure further provides methods to use the multivalent linkers to label multiple primary antibodies of the same species in the same experiment.